0451971 POLYURETHANE GLUE

Hazard statements (CLP)

H315, H317, H319, H334, H335, H336, H351, H373, H412

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. Harmful if inhaled. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled

Hazard pictograms

GHS07 GHS08

Signal word

Danger

Contains

Aromatic polyisocyanate prepolymer

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure. H412 - Harmful to aquatic life with long lasting effects.

Precautionary statements

P201 - Obtain special instructions before use. P260 - Do not breathe dust/fume/gas/mist/vapours/spray. P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P284 - Wear respiratory protection. P304+P340 - IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P321 - Specific treatment (see supplemental first aid instruction on this label). P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.

Supplemental label elements

EUH204 - Contains isocyanates. May produce an allergic reaction.

Additional information

As of August 24, 2023, it is mandatory to have adequate training to proceed with industrial or professional use.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (Inhalation) Not classified Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317 Carcinogenicity, Category 2 H351 Specific target organ toxicity – Single exposure, Category 3, H336 Narcosis Specific target organ toxicity – Single exposure, Category 3, H335 Respiratory tract irritation Specific target organ toxicity – Repeated exposure, Category 2 H373 Hazardous to the aquatic environment – Chronic Hazard, H412 Category 3 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. Harmful if inhaled. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled.